[EN] PRODRUGS OF MYELOPEROXIDASE INHIBITORS<br/>[FR] PROMÉDICAMENTS D'INHIBITEURS DE LA MYÉLOPEROXYDASE
申请人:BIOHAVEN THERAPEUTICS LTD
公开号:WO2021072140A1
公开(公告)日:2021-04-15
Disclosed are prodrugs of myeloperoxidase (MPO) inhibitors, methods of treating MPO related disorders, e.g., multiple system atrophy, amyotrophic lateral sclerosis, and Huntingtons disease, and methods of neuroprotection, which include administering to a patient in need thereof the prodrugs, pharmaceutical compositions including the prodrugs, and kits including the pharmaceutical compositions and instructions for use.
揭示了髓过氧化物酶(MPO)抑制剂的前药,治疗MPO相关疾病的方法,例如多系统萎缩症、肌萎缩侧索硬化和亨廷顿病,以及神经保护方法,包括向需要的患者施用前药,包括前药的药物组合物,以及包括药物组合物和使用说明的工具包。